CN Patent

CN107840830A — 盐酸奥扎莫德无水晶型i

Assigned to Sunshine Lake Pharma Co Ltd · Expires 2018-03-27 · 8y expired

What this patent protects

本发明属于药物化学技术领域，具体涉及盐酸奥扎莫德无水晶型I。本发明的盐酸奥扎莫德无水晶型I具有良好的化学稳定性，和/或生物利用度，具有优良的物理化学性能和成药性能；结晶方法容易控制，重现性好，能有效提高产品质量，适合工业化生产。

USPTO Abstract

本发明属于药物化学技术领域，具体涉及盐酸奥扎莫德无水晶型I。本发明的盐酸奥扎莫德无水晶型I具有良好的化学稳定性，和/或生物利用度，具有优良的物理化学性能和成药性能；结晶方法容易控制，重现性好，能有效提高产品质量，适合工业化生产。

Drugs covered by this patent

ozanimod-hydrochloride (OZANIMOD HYDROCHLORIDE)

Patent Metadata

Patent number: CN107840830A
Jurisdiction: CN
Classification: —
Expires: 2018-03-27
Drug substance claim: No
Drug product claim: No
Assignee: Sunshine Lake Pharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.